Patient-Friendly Explanation
Sometimes a weight-loss medicine is temporarily unavailable because demand has outrun supply, or because of manufacturing or shipping problems. When that happens you may need a different strength, a different product, or a short pause in treatment. Buying from an unverified online seller to bridge the gap is the riskiest option and should be avoided.
Clinical Definition
GLP-1 receptor agonist supply has been constrained repeatedly since 2022 because demand for the active ingredient and single-use pen devices exceeds manufacturing capacity. Abrupt interruption risks loss of glycaemic and weight benefit, return of appetite and, in people with diabetes, metabolic decompensation. Substitution requires attention to dose equivalence between agents, differing titration schedules, device technique and cold-chain storage, and should be planned in advance. Falsified and substandard products circulate through unregulated online channels, so continuity should come from a licensed prescriber or pharmacist.
Why It Matters
A documented bridging plan, agreed before a shortage bites, protects both weight progress and safety. NuLifeCare Singapore’s team reviews available alternatives, dose equivalence and how to restart safely if treatment has to pause.